Previous close | 1.1200 |
Open | 1.1000 |
Bid | 0.7992 x 200 |
Ask | 1.4500 x 200 |
Day's range | 1.1000 - 1.1400 |
52-week range | 0.9750 - 1.8900 |
Volume | |
Avg. volume | 59,550 |
Market cap | 34.791M |
Beta (5Y monthly) | -0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.2000 |
Earnings date | 08 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 2.00 |
Co-Diagnostics ( NASDAQ:CODX ) First Quarter 2024 Results Key Financial Results Net loss: US$9.31m (loss widened by 62...
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript May 9, 2024 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31204 EPS, expectations were $-0.21. CODX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2024.